The activated downstream pathway leads to inhibition of cytotoxic T lymphocytes and reduction of tumor-infiltrating T cells; on the other hand, PD-1/PD-L1 interaction induces the differentiation of CD4+ T cells into Tregs and enhances their suppressive function [44]. The gene discussed is PDCD1; the disease is neoplasm.